Literature DB >> 28637226

Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.

Maeve Mullooly1,2, Zeina G Khodr1, Cher M Dallal3, Sarah J Nyante4, Mark E Sherman5, Roni Falk1, Linda M Liao1, Jeffrey Love6, Louise A Brinton1, Gretchen L Gierach1.   

Abstract

Comparing risk factor associations between invasive breast cancers and possible precursors may further our understanding of factors related to initiation versus progression. Accordingly, among 190,325 postmenopausal participants in the National Institutes of Health-AARP Diet and Health Study (1995-2011), we compared the association between risk factors and incident ductal carcinoma in situ (DCIS; n = 1,453) with that of risk factors and invasive ductal carcinomas (n = 7,525); in addition, we compared the association between risk factors and lobular carcinoma in situ (LCIS; n = 186) with that of risk factors and invasive lobular carcinomas (n = 1,191). Hazard ratios and 95% confidence intervals were estimated from multivariable Cox proportional hazards regression models. We used case-only multivariable logistic regression to test for heterogeneity in associations. Younger age at menopause was associated with a higher risk of DCIS but lower risks of LCIS and invasive ductal carcinomas (P for heterogeneity < 0.01). Prior breast biopsy was more strongly associated with the risk of LCIS than the risk of DCIS (P for heterogeneity = 0.04). Increased risks associated with use of menopausal hormone therapy were stronger for LCIS than DCIS (P for heterogeneity = 0.03) and invasive lobular carcinomas (P for heterogeneity < 0.01). Associations were similar for race, age at menarche, age at first birth, family history, alcohol consumption, and smoking status, which suggests that most risk factor associations are similar for in situ and invasive cancers and may influence early stages of tumorigenesis. The differential associations observed for various factors may provide important clues for understanding the etiology of certain breast cancers. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  DCIS; LCIS; breast cancer; histology; precursors; risk factors

Mesh:

Year:  2017        PMID: 28637226      PMCID: PMC5860557          DOI: 10.1093/aje/kwx206

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

1.  Criteria for definition of overweight in transition: background and recommendations for the United States.

Authors:  R J Kuczmarski; K M Flegal
Journal:  Am J Clin Nutr       Date:  2000-11       Impact factor: 7.045

Review 2.  Evolving concepts in the management of lobular neoplasia.

Authors:  Benjamin O Anderson; Kristine E Calhoun; Eric L Rosen
Journal:  J Natl Compr Canc Netw       Date:  2006-05       Impact factor: 11.908

Review 3.  Recommendations for women with lobular carcinoma in situ (LCIS).

Authors:  Bridget A Oppong; Tari A King
Journal:  Oncology (Williston Park)       Date:  2011-10       Impact factor: 2.990

4.  Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.

Authors:  Tari A King; Melissa Pilewskie; Shirin Muhsen; Sujata Patil; Starr K Mautner; Anna Park; Sabine Oskar; Elena Guerini-Rocco; Camilla Boafo; Jessica C Gooch; Marina De Brot; Jorge S Reis-Filho; Mary Morrogh; Victor P Andrade; Rita A Sakr; Monica Morrow
Journal:  J Clin Oncol       Date:  2015-09-14       Impact factor: 44.544

5.  Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.

Authors:  K Kerlikowske; J Barclay; D Grady; E A Sickles; V Ernster
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

6.  Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Douglas Richesson; Michael F Leitzmann; Gretchen L Gierach; Arthur Schatzkin; Traci Mouw; Albert R Hollenbeck; James V Lacey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.

Authors:  Christie R Eheman; Kate M Shaw; Aliza Blythe Ryerson; Jacqueline W Miller; Umed A Ajani; Mary C White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

8.  The decrease in breast-cancer incidence in 2003 in the United States.

Authors:  Peter M Ravdin; Kathleen A Cronin; Nadia Howlader; Christine D Berg; Rowan T Chlebowski; Eric J Feuer; Brenda K Edwards; Donald A Berry
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

9.  Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.

Authors:  Jasmine Q Lew; Neal D Freedman; Michael F Leitzmann; Louise A Brinton; Robert N Hoover; Albert R Hollenbeck; Arthur Schatzkin; Yikyung Park
Journal:  Am J Epidemiol       Date:  2009-06-18       Impact factor: 4.897

10.  Epidemiology of in situ and invasive breast cancer in women aged under 45.

Authors:  H A Weiss; L A Brinton; D Brogan; R J Coates; M D Gammon; K E Malone; J B Schoenberg; C A Swanson
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more
  8 in total

1.  The Association Between Periodontal Disease and Breast Cancer in a Prospective Cohort Study.

Authors:  Mengmeng Jia; Zeni Wu; Emily Vogtmann; Katie M O'Brien; Clarice R Weinberg; Dale P Sandler; Gretchen L Gierach
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

2.  Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.

Authors:  Cina J Nattenmüller; Mark Kriegsmann; Disorn Sookthai; Renée Turzanski Fortner; Annika Steffen; Britta Walter; Theron Johnson; Jutta Kneisel; Verena Katzke; Manuela Bergmann; Hans Peter Sinn; Peter Schirmacher; Esther Herpel; Heiner Boeing; Rudolf Kaaks; Tilman Kühn
Journal:  BMC Cancer       Date:  2018-05-31       Impact factor: 4.430

Review 3.  Alcohol's Effects on Breast Cancer in Women.

Authors:  Jo L Freudenheim
Journal:  Alcohol Res       Date:  2020-06-18

Review 4.  Interfering Role of ERα on Adiponectin Action in Breast Cancer.

Authors:  Giuseppina Daniela Naimo; Luca Gelsomino; Stefania Catalano; Loredana Mauro; Sebastiano Andò
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-18       Impact factor: 5.555

Review 5.  Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?

Authors:  Samir Zakhari; Jan B Hoek
Journal:  Cancers (Basel)       Date:  2018-09-22       Impact factor: 6.639

6.  Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lynn Rosenberg; Elisa V Bandera; Thaer Khoury; Melissa A Troester; Christine B Ambrosone; Julie R Palmer
Journal:  Breast       Date:  2019-11-06       Impact factor: 4.380

7.  Adherence to the World Cancer Research Fund/American Institute for Cancer Research Recommendations and the Risk of Breast Cancer.

Authors:  Federica Turati; Michela Dalmartello; Francesca Bravi; Diego Serraino; Livia Augustin; Attilio Giacosa; Eva Negri; Fabio Levi; Carlo La Vecchia
Journal:  Nutrients       Date:  2020-02-26       Impact factor: 5.717

8.  Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and risk of in situ breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Authors:  Nena Karavasiloglou; Anika Hüsing; Giovanna Masala; Carla H van Gils; Renée Turzanski Fortner; Jenny Chang-Claude; Inge Huybrechts; Elisabete Weiderpass; Marc Gunter; Patrick Arveux; Agnès Fournier; Marina Kvaskoff; Anne Tjønneland; Cecilie Kyrø; Christina C Dahm; Helene Tilma Vistisen; Marije F Bakker; Maria-Jose Sánchez; María Dolores Chirlaque López; Carmen Santiuste; Eva Ardanaz; Virginia Menéndez; Antonio Agudo; Antonia Trichopoulou; Anna Karakatsani; Carlo La Vecchia; Eleni Peppa; Domenico Palli; Claudia Agnoli; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Salma Tunå Butt; Signe Borgquist; Guri Skeie; Matthias Schulze; Timothy Key; Kay-Tee Khaw; Kostantinos K Tsilidis; Merete Ellingjord-Dale; Elio Riboli; Rudolf Kaaks; Laure Dossus; Sabine Rohrmann; Tilman Kühn
Journal:  BMC Med       Date:  2019-12-02       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.